AIMS: We sought to review cellular changes that occur with reperfusion to try to understand whether ischemia-reperfusion injury (RI) is a potentially modifiable therapeutic target for cardioprotection or neuroprotection in patients undergoing cardiopulmonary resuscitation. DATA SOURCES: Articles written in English and published in PubMed. RESULTS: Remote ischemic conditioning (RIC) involves brief episodes of non-lethal ischemia and reperfusion applied to an organ or limb distal to the heart and brain. Induction of hypothermia involves cooling an ischemic organ or body. Both have pluripotent effects that reduce the potential harm associated with RI in the heart and brain by reduced opening of the mitochondrial permeability transition pore. Recent trials of RIC and induced hypothermia did not demonstrate these treatments to be effective. Assessment of the effect of these interventions in humans to date may have been modified by use of concurrent medications including propofol. CONCLUSIONS: Ongoing research is necessary to assess whether reduction of RI improves patient outcomes.
AIMS: We sought to review cellular changes that occur with reperfusion to try to understand whether ischemia-reperfusion injury (RI) is a potentially modifiable therapeutic target for cardioprotection or neuroprotection in patients undergoing cardiopulmonary resuscitation. DATA SOURCES: Articles written in English and published in PubMed. RESULTS: Remote ischemic conditioning (RIC) involves brief episodes of non-lethal ischemia and reperfusion applied to an organ or limb distal to the heart and brain. Induction of hypothermia involves cooling an ischemic organ or body. Both have pluripotent effects that reduce the potential harm associated with RI in the heart and brain by reduced opening of the mitochondrial permeability transition pore. Recent trials of RIC and induced hypothermia did not demonstrate these treatments to be effective. Assessment of the effect of these interventions in humans to date may have been modified by use of concurrent medications including propofol. CONCLUSIONS: Ongoing research is necessary to assess whether reduction of RI improves patient outcomes.
Authors: Wei-Long Zheng; Edilberto Amorim; Jin Jing; Ona Wu; Mohammad Ghassemi; Jong Woo Lee; Adithya Sivaraju; Trudy Pang; Susan T Herman; Nicolas Gaspard; Barry J Ruijter; Marleen C Tjepkema-Cloostermans; Jeannette Hofmeijer; Michel J A M van Putten; M Brandon Westover Journal: IEEE Trans Biomed Eng Date: 2022-04-21 Impact factor: 4.756